Institut Nationale de la Santé et de la Recherché Médicale, CESP Centre for Research in Epidemiology and Population Health, Unité 1018, Epidemiology of diabetes, obesity and chronic kidney disease over the lifecourse, Villejuif, France.
Diabetes Care. 2010 May;33(5):1044-9. doi: 10.2337/dc09-1901. Epub 2010 Feb 25.
Obstructive sleep apnea is common in patients with type 2 diabetes, and its association with insulin and insulin resistance has been examined in cross-sectional studies. We evaluate risk factors for incident observed sleep apnea in a general population not selected for sleep disturbances.
A total of 1,780 men and 1,785 women, aged 33 to 68 years, from the cohort Data from an Epidemiologic Study on the Insulin Resistance Syndrome (D.E.S.I.R.) responded to the question, "Has someone said to you that you stop breathing during your sleep?" at baseline and 6 years. Anthropometric, clinical, and biological factors were recorded at both time points.
At baseline, 14% of men and 7% of women reported having observed sleep apnea (positive response to question); 6-year incidences were 14 and 6%, respectively. Age, anthropometric parameters, blood pressure, and sleep characteristics were all associated with prevalent, observed apnea episodes, in both sexes. Baseline waist circumference was the strongest predictor of incident apnea: standardized odds ratio (OR), adjusted for age and sex, 1.34 (95% CI 1.19-1.52). After adjustment for age, sex, and waist circumference, the standardized ORs for incident observed apnea were identical for fasting insulin and the homeostasis model assessment of insulin resistance: 1.31 (1.13-1.51) and 1.24 (1.09-1.41) for triglycerides and 1.52 (1.12-2.05) for smoking. Observed apnea at baseline was not associated with changes in anthropometric or biological parameters over the 6-year follow-up.
The most important baseline risk factor for incident apnea was adiposity. After accounting for adiposity, other risk factors were high insulin, insulin resistance, high triglycerides, and smoking, factors amenable to lifestyle intervention.
阻塞性睡眠呼吸暂停在 2 型糖尿病患者中很常见,其与胰岛素和胰岛素抵抗的关系已在横断面研究中进行了研究。我们评估了一般人群中未因睡眠障碍而选择的观察性睡眠呼吸暂停事件的发病风险因素。
共有 1780 名男性和 1785 名女性,年龄 33 至 68 岁,来自队列数据一项关于胰岛素抵抗综合征的流行病学研究(D.E.S.I.R.),在基线和 6 年时都回答了“有人说过你在睡眠中停止呼吸吗?”这个问题。在这两个时间点都记录了人体测量、临床和生物学因素。
基线时,14%的男性和 7%的女性报告有观察到的睡眠呼吸暂停(对问题的阳性反应);6 年的发病率分别为 14%和 6%。在两性中,年龄、人体测量参数、血压和睡眠特征均与现患、观察到的呼吸暂停发作有关。基线时腰围是预测新发呼吸暂停的最强因素:标准化优势比(OR),按年龄和性别调整后为 1.34(95%CI 1.19-1.52)。在调整年龄、性别和腰围后,空腹胰岛素和胰岛素抵抗的稳态模型评估的标准化 OR 对于观察到的新发呼吸暂停是相同的:1.31(1.13-1.51)和 1.24(1.09-1.41)对于甘油三酯和 1.52(1.12-2.05)对于吸烟。基线时观察到的呼吸暂停与 6 年随访期间的人体测量或生物学参数变化无关。
新发呼吸暂停的最重要基线危险因素是肥胖。在考虑肥胖因素后,其他危险因素包括高胰岛素、胰岛素抵抗、高甘油三酯和吸烟,这些因素可通过生活方式干预来改善。